ProKidney Future Growth
Future criteria checks 0/6
ProKidney's earnings are forecast to decline at 25.4% per annum. EPS is expected to decline by 14.5% per annum.
Key information
-25.4%
Earnings growth rate
-14.5%
EPS growth rate
| Biotechs earnings growth | 24.0% |
| Revenue growth rate | n/a |
| Future return on equity | -56.4% |
| Analyst coverage | Low |
| Last updated | 24 Apr 2024 |
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | N/A | -41 | -319 | -119 | 1 |
| 12/31/2024 | N/A | -157 | -91 | -91 | 1 |
| 12/31/2023 | N/A | -35 | -124 | -90 | N/A |
| 9/30/2023 | N/A | -36 | -113 | -80 | N/A |
| 6/30/2023 | N/A | 56 | -85 | -80 | N/A |
| 3/31/2023 | N/A | 43 | -90 | -88 | N/A |
| 12/31/2022 | N/A | -14 | -79 | -77 | N/A |
| 9/30/2022 | N/A | -22 | -76 | -74 | N/A |
| 6/30/2022 | N/A | -31 | -73 | -70 | N/A |
| 3/31/2022 | N/A | -111 | -63 | -59 | N/A |
| 12/31/2021 | N/A | -55 | -55 | -50 | N/A |
| 9/30/2021 | N/A | -49 | -52 | -45 | N/A |
| 12/31/2020 | N/A | -27 | -31 | -25 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PROK is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: PROK is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: PROK is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: Insufficient data to determine if PROK's revenue is forecast to grow faster than the US market.
High Growth Revenue: PROK is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: PROK is forecast to be unprofitable in 3 years.